National Research Council of Canada
1200 Montreal Road, Building M-58
Tel: 613-993-9101 or 1-877-672-2672
38 articles with National Research Council of Canada
Oragenics Enters into Licensing Agreement with the National Research Council of Canada, to Pursue the Rapid Development of Next-Generation SARS-CoV-2 Vaccines
Oragenics, Inc. announced it has entered into a licensing agreement with the National Research Council of Canada that will enable Oragenics to pursue the rapid development of next-generation vaccines against the SARS-CoV-2 virus and its variants.
Bold Therapeutics Receives Additional Funding to Support Development of BOLD-100 as a Novel Antiviral
Bold Therapeutics is pleased to announce that it is receiving advisory services and additional research and development funding of up to CAD$965,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research with Qu’s Novel Immunotherapy Platform
Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce it is receiving advisory services and research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to quickly move forward the potential applic
The National Research Council of Canada formally recognized the scientific impact of the HEK 293 cell line, originally created by Dr. Frank Graham nearly 50 years ago, and its importance in the production of biologic molecules, including current COVID-19 vaccine product candidates.
Canadian Biotech JN Nova Pharma Inc. Partners with the Government of Canada to Develop Therapeutic Platform for COVID-19
JN Nova Pharma Inc. has entered into collaboration with the National Research Council of Canada’s (NRC) Pandemic Response Challenge program to develop a therapeutic pipeline for severe pathologies observed in COVID-19. COVID-19 is not ‘just’ a respiratory infection – it is a complex disease that causes damage to multiple organs, including lung, heart, blood vessels and brain. JN Nova Pharma and the NRC’s team from t
The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19
One of only a handful of vaccine candidates currently in human clinical trials in the world to begin initial evaluation in Canada
Through collaboration, researchers from different organizations can work together to explore, test and validate transformative research ideas that will benefit Canadians.
First round of New Beginnings Initiative will support exploratory collaborative research with 47 researchers across 22 organizations in Canada
GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies
GBS Global Biopharma's proprietary neuropathic pain therapies are orally-delivered, time-released nanoparticles containing myrcene and other cannabinoid-based ingredients
The National Research Council of Canada and Aspect Biosystems work toward new ways to deliver therapeutics to the brain, the holy grail of biopharmaceutical sciences
New 3D therapeutic models of the blood-brain barrier could lead to improved treatments for Alzheimer's, ALS, and other central nervous system diseases
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up
Research agreement for biofermentation development and scale-up processes for cannabinoid biosynthesis in E.coli.
To tackle brain diseases like dementia, leading neuroscientists from the National Research Council of Canada (NRC) and Biogen are putting their heads together to leverage the NRC's unique molecular map of blood vessels that form the blood-brain barrier, to develop new treatments.
Helix Biopharma Announces Agreement In Principle With National Research Council of Canada To Collaborate On Various Immuno-Oncology Initiatives
National Research Council of Canada And KalGene Pharmaceuticals Announce License Agreement For The Development Of Novel Alzheimer's Therapeutics
AvidBiologics Partners With the National Research Council of Canada for Three Novel Antibody-Drug Conjugates
"NeuroTouch" System Provides 3D Graphics and Tactile Feedback During Simulated Brain Surgery, National Research Council of Canada Study
Sirona Biochem Receives Funding From the National Research Council of Canada's Industrial Research Assistance Program
Immunovaccine Inc. Signs Agreement With National Research Council of Canada to Evaluate Carbohydrate-Based Vaccine